Search Videos and More
News
Study: Ablative Stereotactic Magnetic Resonance-Guided Adaptive Radiation Therapy May Improve Overall Survival in Patients with Pancreatic Cancer
A study co-led by researchers at Miami Cancer Institute, part of Baptist Health South Florida, found that ablative stereotactic magnetic resonance (MR)-guided adaptive radiation therapy may improve local control (LC) and overall survival (OS) in patients with borderline resectable (BRPC) and locally advanced pancreas cancer (LAPC).
News
Inaugural Marcus Neuroscience Institute Spine Symposium
The Inaugural Marcus Neuroscience Institute Spine Symposium is a one-day academic event designed to help attendees expand their knowledge of the latest advances in the field of spine surgery through didactic lectures, interactive panel discussions and case-based presentations.
News
Marc Gibber, M.D, is New Medical Director at Baptist Health Bethesda Hospital East
Board-certified cardiothoracic surgeon Marc Gibber, M.D., joins Baptist Health as the new medical director and chief of cardiothoracic surgery at Baptist Health Bethesda Hospital East.
News
When Your Patient Needs an Oral Medicine Evaluation
Whether your patient is being treated for cancer, has an autoimmune disease or an inflammatory condition that is causing an oral problem apart from the teeth and gums, they may benefit from an evaluation and treatment by an oral medicine specialist.
Podcast
AFib, Episode 2: The Ablation Era
In the 2nd episode on atrial fibrillation with Dr. Steven Hoff and Dr. Mario Pascual, we are exploring surgical ablation, Endo/Epicardial Catheter approach for mapping and ablation of AF.
News
Neurologist G. Peter Gliebus, M.D., Joins Baptist Health
G. Peter Gliebus, M.D., a board-certified neurologist with subspecialty certification in behavioral neurology and neuropsychiatry, has joined Marcus Neuroscience Institute, part of Baptist Health, at Boca Raton Regional Hospital.
Podcast
TMS: Making Waves with Treatment Resistant Depression
Join doctors Michael McDermott, M.D. and Rachel Rohaidy, M.D., as they discuss Transcranial Magnetic Stimulation (TMS).
News
Miami Cancer Institute Leads First-in-World Brain Metastasis Trial
Baptist Health Miami Cancer Institute is leading a groundbreaking clinical trial that is studying the use of a new medication combined with stereotactic radiosurgery to combat metastatic brain cancer.
News
Miami Cancer Institute Publication Analyzes Role of Tissue-Agnostic Therapies for the Treatment of Primary Brain Tumors
Researchers from Miami Cancer Institute, part of Baptist Health South Florida, recently published a study in Trends in Cancer that analyzes the use of tissue-agnostic therapeutics in patients with primary brain tumors (PBTs). The publication describes the current and potential impact of tissue-agnostic therapies on the management of PBTs. As part of the publication, the researchers discuss data from clinical trials of tissue-agnostic targets for PBTs in the context of challenges in managing these tumors. They also describe additional tissue-agnostic targets that hold promise for benefiting patients with PBTs.
News
Miami Cancer Institute Precision Oncology Symposium, Second Annual
Live Symposium Friday-Saturday, April 19-20, 2024 The Ritz-Carlton, Coconut Grove, Miami, Florida
News
Advanced Prostate Cancer: Genetic Testing an Invaluable Tool
A study led by Baptist Health Miami Cancer Institute shows that patients with TP53, RB1 and PTEN mutated prostate cancer have a lower overall survival rate than patients who are biomarker negative. The results emphasize the importance of genetic testing for all advanced cancer patients, the researchers say.
Video
Meet the Chief: John Uribe, M.D., Drives Evolution of Orthopedic Care
As head team physician for the Miami Dolphins and Florida Panthers and a lifelong athlete himself, John Uribe, M.D., admits he’s a bit of an adrenaline junkie. It’s a trait that has served him well in his storied career as an orthopedic surgeon with Baptist Health Orthopedic Care.